Tilray Brands Q3 2026 Earnings Review & TLRY Stock Price Prediction

Earnings Review: Tillray Brands Q3 2026

Overview of Earnings Results

• Rod introduces the video, focusing on Tillray Brands' Q3 2026 earnings report and its implications for traders and investors.

• The company missed analyst estimates for EPS but beat revenue expectations, indicating mixed performance.

• Rod shares his personal insights from the conference call, noting a lack of significant takeaways.

Financial Highlights

• Tillray reported net revenues of $207 million with an 11% organic growth; gross profit increased to $55 million (up 6% YoY).

• EPS was reported at negative $0.24 but adjusted to positive $0.02, reflecting better-than-expected operational performance.

• The company maintains a strong balance sheet with $265 million in cash and marketable securities, indicating no net debt.

Market Position and Future Outlook

• Despite challenges like skew rationalization affecting margins (27% vs. 28% YoY), the overall outlook remains positive as they maintain their leadership position in Canada.

• Rod emphasizes that sector recovery is essential for long-term improvement; one or two earnings reports won't significantly impact the market.

Regulatory Environment and Growth Potential

• Discussion on potential rescheduling of cannabis laws in the U.S., which could unlock significant market opportunities for MJ-infused beverages.

• International revenue accelerated sharply, contributing to a 19% increase in overall MJ revenue; medical markets are also expected to grow post-rescheduling.

Product Innovations and Market Trends

• Introduction of new vape products has been well-received; specific flavors like Purple Churro are highlighted as exceptional offerings.

• A narrower loss compared to previous years indicates improving financial health; losses decreased from $793 million last year to $25 million this year.

Technical Analysis Insights

• Rod discusses technical indicators such as descending triangles and bear flags that suggest bearish trends in stock price movements.

• He notes that failure to confirm a daily uptrend raises concerns about future price action, emphasizing caution among investors.

Market Trends and Technical Analysis

Current Market Status

• The speaker notes that the market is still in a daily downtrend, with today's high at 678 being a lower high compared to 708. A confirmation of a daily uptrend is urgently needed.

• The S&P 500 mirrors this trend, remaining in a daily downtrend as well. There are expectations for further downside movement unless an uptrend is confirmed soon.

Indicators and Predictions

• A potential bullish triple thunder could occur if the price surpasses the 10-week moving average while both the stochastic and MACD indicators cross bullishly. Currently, only the stochastic shows bullish signs.

• The analysis highlights several losers in today’s market including IMCC, DB, and Tillray, which typically experiences sell-offs regardless of earnings reports.

Moving Averages and Market Behavior

• A recent death cross occurred when the 50-day moving average crossed above the 200-day moving average. Historically, this leads to temporary relief rallies followed by further declines.

• The speaker explains that after such crosses (both death and golden), there tends to be lagging behavior where price movements precede indicator changes.

Future Outlook

• Despite current struggles, international markets show positive trends with CC Pharma reporting significant growth. However, substantial changes are anticipated once rescheduling occurs in the market context.